Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update

Go back to Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update

Prothena Corp. (PRTA) Tops Q4 EPS by 6c

February 12, 2020 4:37 PM EST

Prothena Corp. (NASDAQ: PRTA) reported Q4 EPS of ($0.54), $0.06 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $256 thousand versus the consensus estimate of $180 thousand.

Net cash used in operating and investing activities was $14.6 million in the fourth quarter and... More